FDA Adverse Event Injury Summary report: N

ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RINGA AND EXTENDED HOLDER - 25MM

MDR report key: 5995392 · Received October 3, 2016

Report

Report Number
1649833-2016-00032
Event Type
Injury
Date Received
October 3, 2016
Date of Event
June 22, 2016
Report Date
October 3, 2016
Manufacturer
ON-X LIFE TECHNOLOGIES, INC
Product Code
LWQ
UDI-DI
00851788001471
PMA / PMN Number
P000037
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE ON-X 614 HEART VALVE DESIGN FMEA 940816 01 REV S THOROUGHLY IDENTIFIES THE PROCESS AND PRODUCT HAZARDS FOR APPROVED INDICATIONS. EACH INDIVIDUAL HAZARD IS MITIGATED AND REDUCED AS LOW AS POSSIBLE BY DESIGN AND PROCESS. POST PRODUCTION RESIDUAL RISK IS COMMUNICATED IN THE PRODUCT'S LABELING AND INSTRUCTION FOR USE (IFU). REOPERATION IS A KNOWN COMPLICATION OF PROSTHETIC VALVE IMPLANTATION AND IS LISTED IN THE IFU. WITHOUT RETURN OF THE VALVE, A SPECIFIC RISK CANNOT BE IDENTIFIED.

Description of Event or Problem · 1

IMPLANT RECOVERY CARD RECEIVED INDICATE THAT PATIENT RECEIVED ONXACE-25 ON (B)(6) 2015 WHICH REQUIRED INTERVENTION/EXPLANT ON (B)(6) 2016 AND REPLACEMENT WITH AN ONXAAP-25 INDICATED FOR "ENLARGED ANEURYSM OF ASCENDING AORTA."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
645725 ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RINGA AND EXTENDED HOLDER - 25MM MECHANICAL HEART VALVE LWQ ON-X LIFE TECHNOLOGIES, INC ONXACE-25 00851788001471

Patients

Seq Age Sex Outcome Treatment
1 45 YR Hospitalization| O